Three world-leading nuclear medicine organizations–the SNMMI Clinical Trials Network (SNMMI-CTN), the Australasian Radiopharmaceutical Trials Network (ARTnet), and the…
IntroductionWhat are smart drugs?Why multi-target approaches matterAdvantagesChallengesFuture outlookReferencesFurther reading Smart multi-target drugs are reshaping modern therapeutics by addressing…